HVTN 116

A Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Viral Activity of VRCHIVMAB060-00-AB (VRC01) and VRC-HIVMAB080-00-AB (VRC01LS) in the Serum and Mucosa of Healthy, HIV-Uninfected Adult Participants

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID) June 15, 2016
VRC-HIVMAB060-00-AB ,VRCHIVMAB080-00-AB VRC01 antibody and VRC01 modified modified for FcRn affinity
VRC-HIVMAB060-00-AB Passive Immunization
VRCHIVMAB080-00-AB Passive Immunization
South Africa, USA 101